Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bornebusch, Annika Billefeld ; Mason, Graeme F ; Tonetto, Simone ; Damsgaard, Jakob ; Gjedde, Albert ; Fink-Jensen, Anders ; Thomsen, Morgane. / Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice. In: Psychopharmacology. 2021 ; Vol. 238, No. 3. pp. 833-844.

Bibtex

@article{b29bc2db849c41eca2276ea5c0bc31de,
title = "Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice",
abstract = "RATIONALE: After alcohol ingestion, the brain partly switches from consumption of glucose to consumption of the alcohol metabolite acetate. In heavy drinkers, the switch persists after abrupt abstinence, leading to the hypothesis that the resting brain may be {"}starved{"} when acetate levels suddenly drop during abstinence, despite normal blood glucose, contributing to withdrawal symptoms. We hypothesized that ketone bodies, like acetate, could act as alternative fuels in the brain and alleviate withdrawal symptoms.OBJECTIVES: We previously reported that a ketogenic diet during alcohol exposure reduced acute withdrawal symptoms in rats. Here, our goals were to test whether (1) we could reproduce our findings, in mice and with longer alcohol exposure; (2) ketone bodies alone are sufficient to reduce withdrawal symptoms (clarifying mechanism); (3) introduction of ketogenic diets at abstinence (a clinically more practical implementation) would also be effective.METHODS: Male C57BL/6NTac mice had intermittent alcohol exposure for 3 weeks using liquid diet. Somatic alcohol withdrawal symptoms were measured as handling-induced convulsions; anxiety-like behavior was measured using the light-dark transition test. We tested a ketogenic diet, and a ketone monoester supplement with a regular carbohydrate-containing diet.RESULTS: The regular diet with ketone monoester was sufficient to reduce handling-induced convulsions and anxiety-like behaviors in early withdrawal. Only the ketone monoester reduced handling-induced convulsions when given during abstinence, consistent with faster elevation of blood ketones, relative to ketogenic diet.CONCLUSIONS: These findings support the potential utility of therapeutic ketosis as an adjunctive treatment in early detoxification in alcohol-dependent patients seeking to become abstinent.TRIAL REGISTRATION: clinicaltrials.gov NCT03878225, NCT03255031.",
keywords = "Alcohol dependence, Alcohol withdrawal, Alcoholism, Anxiety-like behavior, Detoxification, Ethanol, Ketone bodies, Ketone monoester, Mice",
author = "Bornebusch, {Annika Billefeld} and Mason, {Graeme F} and Simone Tonetto and Jakob Damsgaard and Albert Gjedde and Anders Fink-Jensen and Morgane Thomsen",
note = "Publisher Copyright: {\textcopyright} 2021, Springer-Verlag GmbH Germany, part of Springer Nature. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = mar,
doi = "10.1007/s00213-020-05735-1",
language = "English",
volume = "238",
pages = "833--844",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer",
number = "3",

}

RIS

TY - JOUR

T1 - Effects of ketogenic diet and ketone monoester supplement on acute alcohol withdrawal symptoms in male mice

AU - Bornebusch, Annika Billefeld

AU - Mason, Graeme F

AU - Tonetto, Simone

AU - Damsgaard, Jakob

AU - Gjedde, Albert

AU - Fink-Jensen, Anders

AU - Thomsen, Morgane

N1 - Publisher Copyright: © 2021, Springer-Verlag GmbH Germany, part of Springer Nature. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/3

Y1 - 2021/3

N2 - RATIONALE: After alcohol ingestion, the brain partly switches from consumption of glucose to consumption of the alcohol metabolite acetate. In heavy drinkers, the switch persists after abrupt abstinence, leading to the hypothesis that the resting brain may be "starved" when acetate levels suddenly drop during abstinence, despite normal blood glucose, contributing to withdrawal symptoms. We hypothesized that ketone bodies, like acetate, could act as alternative fuels in the brain and alleviate withdrawal symptoms.OBJECTIVES: We previously reported that a ketogenic diet during alcohol exposure reduced acute withdrawal symptoms in rats. Here, our goals were to test whether (1) we could reproduce our findings, in mice and with longer alcohol exposure; (2) ketone bodies alone are sufficient to reduce withdrawal symptoms (clarifying mechanism); (3) introduction of ketogenic diets at abstinence (a clinically more practical implementation) would also be effective.METHODS: Male C57BL/6NTac mice had intermittent alcohol exposure for 3 weeks using liquid diet. Somatic alcohol withdrawal symptoms were measured as handling-induced convulsions; anxiety-like behavior was measured using the light-dark transition test. We tested a ketogenic diet, and a ketone monoester supplement with a regular carbohydrate-containing diet.RESULTS: The regular diet with ketone monoester was sufficient to reduce handling-induced convulsions and anxiety-like behaviors in early withdrawal. Only the ketone monoester reduced handling-induced convulsions when given during abstinence, consistent with faster elevation of blood ketones, relative to ketogenic diet.CONCLUSIONS: These findings support the potential utility of therapeutic ketosis as an adjunctive treatment in early detoxification in alcohol-dependent patients seeking to become abstinent.TRIAL REGISTRATION: clinicaltrials.gov NCT03878225, NCT03255031.

AB - RATIONALE: After alcohol ingestion, the brain partly switches from consumption of glucose to consumption of the alcohol metabolite acetate. In heavy drinkers, the switch persists after abrupt abstinence, leading to the hypothesis that the resting brain may be "starved" when acetate levels suddenly drop during abstinence, despite normal blood glucose, contributing to withdrawal symptoms. We hypothesized that ketone bodies, like acetate, could act as alternative fuels in the brain and alleviate withdrawal symptoms.OBJECTIVES: We previously reported that a ketogenic diet during alcohol exposure reduced acute withdrawal symptoms in rats. Here, our goals were to test whether (1) we could reproduce our findings, in mice and with longer alcohol exposure; (2) ketone bodies alone are sufficient to reduce withdrawal symptoms (clarifying mechanism); (3) introduction of ketogenic diets at abstinence (a clinically more practical implementation) would also be effective.METHODS: Male C57BL/6NTac mice had intermittent alcohol exposure for 3 weeks using liquid diet. Somatic alcohol withdrawal symptoms were measured as handling-induced convulsions; anxiety-like behavior was measured using the light-dark transition test. We tested a ketogenic diet, and a ketone monoester supplement with a regular carbohydrate-containing diet.RESULTS: The regular diet with ketone monoester was sufficient to reduce handling-induced convulsions and anxiety-like behaviors in early withdrawal. Only the ketone monoester reduced handling-induced convulsions when given during abstinence, consistent with faster elevation of blood ketones, relative to ketogenic diet.CONCLUSIONS: These findings support the potential utility of therapeutic ketosis as an adjunctive treatment in early detoxification in alcohol-dependent patients seeking to become abstinent.TRIAL REGISTRATION: clinicaltrials.gov NCT03878225, NCT03255031.

KW - Alcohol dependence

KW - Alcohol withdrawal

KW - Alcoholism

KW - Anxiety-like behavior

KW - Detoxification

KW - Ethanol

KW - Ketone bodies

KW - Ketone monoester

KW - Mice

UR - http://www.scopus.com/inward/record.url?scp=85099096441&partnerID=8YFLogxK

U2 - 10.1007/s00213-020-05735-1

DO - 10.1007/s00213-020-05735-1

M3 - Journal article

C2 - 33410985

VL - 238

SP - 833

EP - 844

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 3

ER -

ID: 62440431